Mindfulness training for Pregnancy-Induced Hypertension (PIH)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pregnancy-Induced Hypertension (PIH)Mindfulness training - Behavioral
Eligibility
18 - 60
Female
What conditions do you have?
Select

Study Summary

This trial will test whether a mindfulness intervention can help prevent hypertensive disorders of pregnancy, which are a leading cause of maternal morbidity and mortality. The intervention will be delivered via phone, and participants will be asked to wear a wrist-worn biosensor.

Eligible Conditions
  • Pregnancy-Induced Hypertension (PIH)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Before and after the intervention, approximately 3 months

Month 3
Heart rate response to momentary stress
Perceived and received support in response to momentary stress
Perceived stress and mood responses to momentary stress

Trial Safety

Trial Design

1 Treatment Group

Mindfulness training
1 of 1

Experimental Treatment

150 Total Participants · 1 Treatment Group

Primary Treatment: Mindfulness training · No Placebo Group · N/A

Mindfulness training
Behavioral
Experimental Group · 1 Intervention: Mindfulness training · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness training
2005
Completed Phase 3
~1830

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: before and after the intervention, approximately 3 months

Who is running the clinical trial?

LifespanLead Sponsor
37 Previous Clinical Trials
33,780 Total Patients Enrolled
Margaret H BublitzPrincipal InvestigatorThe Miriam Hospital

Eligibility Criteria

Age 18 - 60 · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a blood pressure of 140/90 or less.